oleanolic acid 3-acetate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, MG; Chung, IS; Hwang-Bo, J; Park, JH | 1 |
| Choi, JK; Ha, YS; Kim, DS; Kim, SH; Kim, SW; Kwon, TK; Lee, JY; Lee, S; Oh, HM; Park, PH; Rho, MC; Shin, TY; Yoo, J | 1 |
2 other study(ies) available for oleanolic acid 3-acetate and Disease Models, Animal
| Article | Year |
|---|---|
3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Humans; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Sentinel Lymph Node; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes.
Topics: Adult; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Cell Survival; Cells, Cultured; Dexamethasone; Disease Models, Animal; Down-Regulation; Fibroblasts; Humans; Immunoglobulin G; Ketoprofen; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Mice; Mice, Inbred DBA; Middle Aged; Mitogen-Activated Protein Kinases; NF-kappa B; Synovial Membrane; T-Lymphocytes; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |